Who we are

Pierre-Emmanuel Rautou (MD, PhD) is a clinical specialist in Hepatology with a PhD in vascular biology (2011). He is Professor of Hepatology at Université Paris-Cité and Hôpital Beaujon (Clichy, France) since 2016. He is the head of the splanchnic hemodynamic laboratory at Beaujon Hospital (Clichy, France) since 2012. He is also leading an Inserm team dedicated to the study of the role of vessels in liver diseases, at the INSERM Unit 1149 (Paris Research Center on Inflammation). His research is focused on the role of vessels in liver diseases. Specifically, he is interested in primary vascular liver diseases (portal vein thrombosis and porto-sinusoidal vascular disorder), as well as in vascular involvement in common liver diseases development and complications (extracellular vesicules, coagulation, endothelial cells). He is the chair of the COST EuroVALDINET.

Andrea De Gottardi is professor and co-head of Gastroenterology and Hepatology at Luzerner Kantonsspital in Lucerne, Switzerland. He leads a research group working on the effects of the intestinal bacterial flora on the regulation of blood flow and portal hypertension. As a researcher-clinician, he contributes to multicentre projects on thrombotic and vascular disorders of the liver and participates in several international studies including the European Reference Network on Rare Liver Diseases He has served as chair of the EASL-VALDIG Consortium and as president of the Swiss Association for the Study of the Liver. He has been co-founder of the Swiss liver patient association and organizes the annual Hepatology-Preceptorship.

Juan Carlos García-Pagán is a Senior consultant in Hepatology and Head of the Hepatic Hemodynamic section at the Hospital Clinic in Barcelona, Spain and Associate Professor at the University of Barcelona. His main research of Interest include the pathophysiology and treatment of portal hypertension in cirrhosis; treatment of variceal bleeding in patients with cirrhosis, and the natural history and treatment of vascular liver diseases. He was cofounder and former chair until 2019 of the EASL-VALDIG (Vascular liver disease group).

Dominique Valla is Professor Emeritus of Hepatology at Université Paris-Cité, Assistance Publique-Hôpitaux de Paris and Inserm, He has been the head of the Liver Unit, Hôpital Beaujon. He has been a co-founder and coordinator of the European (EN-Vie and VALDIG) and French (CRMVF) networks for vascular disorders of the liver. His clinical and academic activities, have long been focused on portal hypertension and rare liver diseases, particularly vascular disorders, and later broadened to the diagnosis of NASH in patients with type-2 diabetes.